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Abstract
Background: In this study, we established a hypothetical tumor-lodds-metastasis (TLM) and tumor-ratio-metastasis (TRM)
staging system. Moreover, we compared them with the 7
th edition of American Joint Committee on Cancer tumor-nodes-
metastasis (AJCC TNM) staging system in gastric cancer patients after D2 resection.
Methods: A total of 1000 gastric carcinoma patients receiving treatment in our center were selected for the analysis. Finally,
730 patients who received D2 resection were retrospectively studied. Patients were staged using the TLM, TRM and the 7
th
edition AJCC TNM system. Survival analysis was performed with a Cox regression model. We used two parameters to
compare the TNM, TRM and TLM staging system, the 22log likelihood and the hazard ratio.
Results: The cut points of lymph node ratio (LNR) were set as 0, 0–0.3, 0.3–0.6, 0.6–1.0. And for the log odds of positive
lymph nodes (LODDS), the cut points were established as#20.5, 20.5-0, 0-0.5, .0.5. There were significant differences in
survival among patients in different LODDS classifications for each pN or LNR groups. When stratified by the LODDS
classifications, the prognosis was highly homologous between those in the according pN or LNR classifications. Multivariate
analysis showed that TLM staging system was better than the TRM or TNM system for the prognostic evaluation.
Conclusions: The TLM system was superior to the TRM or TNM system for prognostic assessment of gastric adenocarcinoma
patients after D2 resection.
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Introduction
Approximately one million people are diagnosed each year with
gastric cancer, making it the fourth most common cancer and the
second leading cause of cancer related death worldwide with an
estimated 800,000 deaths caused by the disease [1]. The incidence
of gastric cancer varies widely according to geographic region and
is particularly common in Asia [2]. Until now the prognosis for
gastric adenocarcinoma patients stays poor and Tumor-Node-
Metastasis (TNM) staging system has been proved to be a
prognostic factor which can effectively predict the prognosis of
gastric adenocarcinoma patients [3]. From January 1, 2010 on, the
most recent revision of American Joint Committee on Cancer
(AJCC) TNM stage for carcinoma of gastric (the 7
th edition) was
put into use [4]. Our previous study has shown that the 7
th edition
of AJCC TNM staging system was more reasonable compared
with the AJCC 6
th system in predicting the survival of gastric
cancer patients to a certain degree [5]. However, some authors
pointed out that the value of the latest number-based pN
classification in the AJCC TNM staging system was affected by
the number of lymph nodes retrieved [6–13]. A new ratio-based
lymph nodes system (rN) has been proposed, which was defined as
the ratio of the metastatic lymph nodes and the total number of
retrieved lymph nodes after the resection. Recently, some studies
has indicated that the TRM (Tumor-Ratio-Metastasis) staging
system can be an alternative to the traditional TNM staging
system [14]. However, some authors concerned that almost half of
the Asian patients would not benefit from the ratio-based
classification system since the definition of the rN0 classification
was congruent with the pN0 classification [13].
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31736Log odds of positive lymph nodes (LODDS), is defined as the
log of the ratio between numbers of positive lymph nodes and the
numbers of negative lymph nodes. To avoid singularity, 0.5 is
usually added to both the numbers of positive lymph nodes and
negative lymph nodes, log
(pnodz0:5)
(tnod{pnodz0:5), in which the pnod is the
number of positive lymph nodes and tnod means the total number
of lymph nodes retrieved [15]. Sun et al. studied 2,547 gastric
cancer patients and concluded that the LODDS system was more
reliable than the Union Internationale Contre le Cancer (UICC)
and AJCC pN system and the rN system for prognostic assessment
[13]. Till now, there is no study focus on the prognostic
significance of the tumor-lodds-metastasis (TLM) stage system
for gastric cancer patients after D2 resection. The aim of our study
is to compare the TLM, tumor-ratio-metastasis (TRM) and the 7th
AJCC TNM staging system in prognostic assessment for
carcinoma of the gastric after D2 resection in China.
Results
Patient demographics
The median age of the 730 patients was 60 years (range 24–83
years). Among them, 522 were male and 208 were female. The
overall 5-year survival for the whole group of patients was 55.4%,
with median survival of 78.0 months. The median follow-up for
the entire cohort was 48.0 months (range 3.0–175.0 months). The
characteristics of the 730 gastric adenocarcinoma patients and the
effect of clinical features on survival were summarized in Table 1.
The total number of dissected lymph nodes was 12374, with an
average of 17.0611.4 (means6s.d.) dissected nodes per case
(median 16.0, range 0–72). The mean number of metastatic nodes
was 7.865.0 (median 4, range 0–70) in the overall series and
9.767.6 (median 7, range 1–70) in lymph nodes positive patients.
The number of excised lymph nodes was less than 15 in 21.6% of
patients who received resection.
The classification of rN and LODDS intervals
Table 2 listed the patient numbers and the 5-year survival rates
of different groups according to the value of rN with an interval of
0.1 (ranging from 0 to 1.0). As shown, 4 groups were identified by
combining patients with similar prognosis. Accordingly, a novel N
classification, rN classification was established: R0 (rN=0), R1
(0,rN#0.3), R2 (0.3,rN#0.6), R3 (0.6,rN#1.0). The 5-year
survival rates of R0, R1, R2 and R3 patients were 72.1%, 65.6%,
30.3% and 13.0%, respectively (P,0.001, Figure 1).
The value of LODDS ranged from 22.05 to 1.93. Table 3 listed
the patient numbers and the 5-year survival rates of different
groups according to the value of LODDS with an interval of 0.5.
Since only three patients with a LODDS smaller than 22.00, we
combined patientsinthe groupLODDS#22.00andpatientsinthe
group 22.00,LODDS#21.50 together.Asshown,weidentified4
groups by combining patients with similar prognosis. Another novel
N classification, LODDS classification was then established:
LODDS1 (LODDS#20.5), LODDS2 (0.5,LODDS#0),
LODDS3 (0,LODDS#0.5), LODDS4 (0.5,LODDS). The
5-year survival rates of LODDS1, LODDS2, LODDS3 and
LODDS4 patients were 71.2%, 47.9%, 25.9% and 14.8%,
respectively (P,0.001, Figure 2).
The 5-year survival rates of N0, N1, N2 and N3 (AJCC N
classification) patients were 72.1%, 63.7%, 53.9% and 26.8%,
respectively (P,0.001, Figure 3).
The Kaplan-Meier plots shown a good discriminatory ability
among each group in these three N classifications.
Table 4 listed the 5-year survival rates of patients with different
pN and rN classifications, stratified by LODDS. As shown, for
Table 1. Demographics and univariate survival analysis
results of the 730 gastric carcinoma patients.
Factors Numbers 5 years OS (%) P value
Gender
Male 522 55.2
female 208 56.0 0.544
Age median 60
,60 386 60.0
$60 344 50.2 0.004
Tumor size
#5 cm 470 61.5
.5 cm 260 44.7 ,0.001
Anemia
Yes 127 60.6
No 309 70.1 0.038
Location of tumor
Proximal 304 46.4
distal 426 58.3 ,0.001
Degree of differentiation
Well+Moderate 200 54.1
Poor+signet ring cell 530 45.8 0.007
Total number of LN retrieved
,15 158 47.5
$15 572 60.2 ,0.001
The 7




T4 274 49.4 ,0.001
The 7




N3 182 26.8 ,0.001




R3 125 13.0 ,0.001




LODDS4 109 14.8 ,0.001
The 7







IIIC 182 26.3 ,0.001
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differences in survival could always be observed among patients
in different LODDS classification. For patients in each LODDS
classification, prognosis was highly homologous between those in
different pN or rN classifications. These results indicated that the
LODDS classification is superior to the pN and rN classifications
for prognostic assessment.
Univariate and multivariate analyses of 5-year overall
survival
Both univariate and multivariate analyses were used to evaluate
factors relating to 5-year overall survival. The items of age, tumor
size, status of anemia, location of tumor, degree of differentiation,
total number of lymph nodes retrieved, pT classification, pN
classification, rN classification, LODDS and three staging systems
were significantly related to 5-year overall survival (Table 1). In the
AJCC 7
th TNM staging system the 5-year overall survival rates of
patients from stage IA to stage IIIC were 92.3% vs 87.2% vs 74.2%
vs 71.3% vs 56.5% vs 46.7% vs 26.3%, respectively (P,0.001,
Figure 4). There was similar survival curves between stages IIA and
IIB. While in the TRM and TLM staging systems, no overlapping
survival curve was found in the seven subgroups (Figures 5 and 6).
The 5-years survival rates of patients from stage IA to stage IIIC in
the TRM staging system were 92.3% vs 88.7% vs 83.9% vs 68.7%
vs60.7%vs35.7%vs20.5%(P,0.001).IntheTLMstagingsystem,
thesurvivalrates were93.8%vs85.9%vs78.3%vs65.2%vs52.3%
vs 30.1% vs 12.4%, respectively (P,0.001).
For the multivariable regression analysis, we firstly set up a
model including age, status of anemia, size of tumor, tumor
location, degree of differentiation, total number of lymph nodes
retrieved and AJCC 7th TNM staging system. Then we set up a
second model which was identical to the first one except that the
AJCC 7th TNM staging system was replaced by the TRM staging
system. In the third model we used the TLM staging system to
replace the TRM system. We used two parameters to compare the
TNM, TRM and TLM staging system, the 22log likelihood and
the hazard ratio (HR). The higher the HR, the better the system.
While the smaller the 22log likelihood, the better the system.
Though in the three multivariable regression analysis systems,
TNM, TRM and TLM were all independent factors for the
overall survival (P,0.001 for these three parameters, Table 5). We
found that the 22log likelihood of these three staging system were
1393.437, 1386.707 and 1382.555 for the TNM, TRM and TLM
staging system, respectively. While the HRs were 1.366, 1.463 and
1.504 for the TNM, TRM and TLM staging system, respectively.
Therefore we considered the TLM system was superior to the
TRM and TNM system (Table 5).
Discussion
For decades, the involvement of regional lymph nodes with
cancer in malignant diseases has been considered as one of the
most important prognostic factors. Other information pertaining
to the total numbers of lymph nodes and negative lymph nodes has
become the focus of studies in these years [15]. LNR and LODDS
were two new indices that have been considered important and
promising recently. The superiority of LNR as a prognostic
classification in various malignancies, including gastric cancer,
compared to the pN classification which is basing on the absolute
number of metastasis lymph nodes (MLN) in predicting prognosis
of gastric cancer patients [10,12,14].
There is little data on the study of LODDS. Considering its
unique statistical characteristic, LODDS has the potential to
become a superior prognostic index. Our study shown that the
LODDS classification was superior to the pN and rN classifica-
tions for prognostic assessment. In an analysis of the prognostic
factors related to lymph nodes in 24,477 colon cancer patients
extracted from the SEER database, Wang et al. [15] concluded
that LODDS was a better prognostic factor than LNR. Vinh-
Hung et al. [16] and Yildirm et al [17] both reached another
conclusion that the estimated LODDS provided similar result to
those with LNR basing on the analysis of node positive breast
cancer patients. There were several reasons that made LODDS
classification superior to the rN and pN classification. Sun et al.
[13] proposed that it might because of its potential of
discriminating patients with the same ratio of nodes metastasis
















IIIC 114 12.4 ,0.001
Abbreviations: AJCC, American Joint Committee on Cancer; TNM, Tumor-Node-
Metastasis; TRM, Tumor-Ratio-Metastasis; TLM, Tumor-Lodds-Metastasis.
doi:10.1371/journal.pone.0031736.t001
Table 1. Cont.
Table 2. Overall survival rates of gastric cancer patients with
D2 resection according to the value of lymph nodes ratio (rN)
with the interval of 0.1 (ranging from 0 to 1).
No. 5-YSR(%) P
a
rN=0 267 72.1 0.039
0,rN#0.1 66 68.0 0.897
0.1,rN#0.2 70 67.3 0.921
0.2,rN#0.3 59 67.5 0.007
0.3,rN#0.4 62 40.2 0.373
0.4,rN#0.5 52 33.9 0.677
0.5,rN#0.6 29 32.9 0.021
0.6,rN#0.7 33 24.4 0.418
0.7,rN#0.8 39 21.3 0.092
0.8,rN#0.9 22 12.7 0.597
0.9,rN#1.0 31 10.2
5-YSR, 5-year survival rate.
aCompared between adjacent groups.
doi:10.1371/journal.pone.0031736.t002
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was a function of the number of negative lymph nodes, whereas
LNR was a function of total number of lymph nodes. In our study,
we compared the overall survival rates of patients in different pN,
rN and LODDS classifications and we observed that all the three
N classifications were all significant different in predicting the
survival. Moreover, we found that the significant differences in
survival could always be found for patients in each of the pN or rN
classifications when stratifying by LODDS. However, prognosis
was highly homologous for patients in each of the LODDS
classifications when stratifying by the pN or rN classifications. It is
one evidence showing that the superiority of LODDS over the
LNR or the AJCC N stage in gastric cancer.
Wang et al.[14] analyzed 1343 cases of gastric cancer patients who
underwent D2 resection and clasified the cut points of LNR as 0,
0–0.3, 0.3–0.6 and .0.6. They concluded that the TRM staging
system may be considered as an alternative to the 7
th TNM system.
While in some other reports the best cut points of LNR differed. In
the study carried out by Bando et al. [18], it was 0, 0–0.1, 0.1–0.25
and $0.25. Sun et al. [13] analyzed 2547 cases of gastric cancer
patients and classified the bestcut points of LNR as 0, 1–0.2, 0.21–0.5
and .0.5. The intervals of N ratio classification were determined in
our study by comparing the overall survival rates according to the rN
with an initial interval of 0.1 and combing patients with similar
prognosis. The intervals of LODDS were also determined by using
the best cutoff approach and considering the patients’ survival (log-
rank statistic) with an initial interval of 0.5 as the dependent variable.
According to this, in our manuscript, the cut points of lymph node
ratio were set as 0, 0–0.3, 0.3–0.6, 0.6–1.0. And for the log odds of
positive lymph nodes (LODDS), the cut points were established
as#20.5, 20.5-0, 0-0.5, .0.5. Only 4 groups were identified by
combining patients with similar prognosis which is comparible with
the N classification in the AJCC 7
th staging system. While Sun et al.
[13] established the LODDS classifications as #21.5,
21.5,LODDS#21.0, 21.0,LODDS#20.5, 20.5,LODDS#0
and .0.
Basing on the superiority of LODDS to LNR and the pN
classification, we therefore combined the pT stage and the two new
N classifications (LODDS and rN) together to form the hypothetical
TLM, TRM staging system and then compared them with the
AJCC TNM staging system. The main finding of the present study
Table 3. Overall survival rates of gastric cancer patients with
D2 resection according to the value of LODDS with the
interval of 0.5 (ranging from 22.05 to 1.93).
No. 5-YSR(%) P
a
LODDS#21.5 96 75.7 0.418
21.5,LODDS#21.0 123 73.4 0.270
21.0,LODDS#20.5 86 65.3 ,0.001
20.5,LODDS#0 174 47.9 0.009
0,LODDS#0.5 142 25.9 0.005
0.5,LODDS#1.0 48 12.2 0.342
1.0,LODDS#1.5 28 17.0 0.437
LODDS.1.5 33 11.0
5-YSR, 5-year survival rate.
aCompared between adjacent groups.
doi:10.1371/journal.pone.0031736.t003
Figure 1. Survival curves of gastric cancer patients with D2 resection according to rN stage.
doi:10.1371/journal.pone.0031736.g001
Tumor-Lodds-Metastasis System in Gastric Cancer
PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e31736isthatthenewTLMstagingsystemissuperiortothe TRMorTNM
staging system for prognostic prediction by using Cox regression
multivariate analysis. Though the Kaplan-Meier plot shown a good
discriminatory ability among stages IA through IIIC with all the
three staging systems, we found that there was no significant
differencebetween patientswith stageIIAandIIB,P=0.589.which
was similar to our previous study [5]. The implementation of TLM
staging system led to the identification of subgroups of patients
Figure 2. Survival curves of gastric cancer patients with D2 resection according to LODDS stage.
doi:10.1371/journal.pone.0031736.g002
Figure 3. Survival curves of gastric cancer patients with D2 resection according to AJCC 7
th N stage.
doi:10.1371/journal.pone.0031736.g003
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or TRM system. Though in the three multivariable regression
analysis systems, TNM, TRM and TLM were all independent
factors for the overall survival (P,0.001 for these three parameters.
Table 5). We found that the 22log likelihood of the TLM staging
system was the lowest and the HRs of the TLM staging system was
the highest. Therefore we considered the TLM system was superior
to the TRM and TNM system.
In our study, all the patients received D2 lymphadenectomy
with R0 resection, and the majority of patients (78.4%) had more
than 15 lymph nodes retrieved. Therefore we did not discuss the
effect of lymph node number retrieved on the three staging
systems.
The authors are not aware of any other studies addressing the
superiority ofTLMstagingsystem ingastriccancer inChina. In this
investigation performed with 730 gastric adenocarcinoma we came
to the following conslusions: 1) LODDS is superior to pN or rN
classifications inpredicting the 5-yearoverall survival rates of gastric
adenocarcinoma patients. 2) The TLM staging system was better
than the TRM or TNM.in predicting the overall survival of patients
with gastric adenocarcinoma after D2 resection. Incorporating
LODDS into the staging system of gastric cancer will enable
clinicians to more accurately predict the prognosis of patients. The
limitation of current study is in its retrospective analysis setting and
from a single-institution experience. The impact of various
treatments related outcome could not be evaluated fully in this
study. External validation by using other large database for
evaluating the prognostic effect of LODDS and TLM system must
be taken prior to the recommendation for its practical usage.
Methods
Ethics Statement
All patients provided written informed consent for their
information to be stored in the hospital database; we obtained
Table 4. Overall survival rates with different pN and rN
classifications stratified by the LODDS staging system.












N0 209 71.1 48 61.8 10 42.6 - - 0.035
N1 51 68.0 39 55.2 23 33.3 - - 0.04
N2 37 77.2 59 49.2 40 29.1 32 18.2 ,0.001
N3 8 75.0 28 38.8 69 24.7 77 13.6 0.005
P
b 0.796 0.396 0.872 0.892
R stage
R0 205 70.3 54 60.4 8 42.0 - - 0.009
R1 100 71.3 85 51.6 10 29.4 - - 0.026
R2 - - 35 47.3 78 28.7 30 15.4 0.018
R3 - - - - 46 26.3 79 14.8 0.003
P
c 0.827 0.497 0.329 0.920
Abbreviations: LODDS, Log Odds of Positive Lymph Nodes; No, number of
patients; 5-YSRs, 5-year survival rate.
aComparison of overall survival rates between different LODDS groups.
bComparison of overall survival rates between different pN groups.
cComparison of overall survival rates between different rN groups.
doi:10.1371/journal.pone.0031736.t004
Figure 4. Survival curves of gastric cancer patients with D2 resection according to AJCC TNM staging system.
doi:10.1371/journal.pone.0031736.g004
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doi:10.1371/journal.pone.0031736.g005
Figure 6. Survival curves of gastric cancer patients with D2 resection according to TLM staging system.
doi:10.1371/journal.pone.0031736.g006
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from independent ethics committees at Cancer Center of Sun Yat-
Sen University. The study was undertaken in accordance with the
ethical standards of the World Medical Association Declaration of
Helsinki.
Patients
Between January 1996 and January 2006, the medical records
of 1000 pathology-proven gastric adenocarcinoma patients who
were diagnosed and received treatment in the Cancer Center of
Sun Yat-Sen University were retrospectively analyzed. Eligibility
criteria were: (1) patients aged between 18 and 75 years of age, (2)
patients receiving D2 resection carried out by experienced
surgeons in our hospital following the Japanese Gastric Cancer
Association (JGCA) guidelines [19], without macroscopic or
microscopic residual tumor, (3) patients with a $3 months
postoperative survival time and (4) patients without a history of
other prior malignancy. Finally, 730 patients were included for the
analysis.
The intervals of rN classification were determined by comparing
overall survival rates according to rN with an initial interval of 0.1
and combining patients with similar prognosis (Table 2). Similarly,
LODDS classification intervals were determined by comparing
overall survival rates according to the value of LODDS with an
initial interval of 0.5 and combing patients with similar prognosis
(Table 3).
To make the study compatible with the 7
th edition of AJCC
TNM staging system, we proposed another two staging systems on
the basis of rN and LODDS classifications respectively. Consid-
ering that no patients with distant metastasis were included in this
study, there is no stage IV patients in these three staging systems.
The TRM staging system is as follows: IA, T1R0; IB, T1R1,
T2R0; IIA, T1R2, T2R1, T3R0; IIB, T1R3, T2R2, T3R1,
T4aR0; IIIA, T2R3, T3R2, T4aR1; IIIB, T3R3, T4aR2, T4bR0,
T4bR1; IIIC, T4aR3, T4bR2, T4bR3. The TLM staging system
is as follows: IA, T1L1; IB, T1L2, T2L1; IIA, T1L3, T2L2, T3L1;
IIB, T1L4, T2L3, T3L2, T4aL1; IIIA, T2L4, T3L3, T4aL2; IIIB,
T3L4, T4aL3, T4bL1, T4bL2; IIIC, T4aL4, T4bL3, T4bR4.
Clinical data collected for subsequent analysis included gender
(male or female), age at diagnosis (,60 or $60. The median age
was 60.), tumor size (#5c mo r.5 cm), anemia (yes or no),
primary tumor site (proximal or distal), degree of differentiation
(well+moderate differentiated carcinoma or poor+signet ring cell
differentiated carcinoma), total number of lymph nodes retrieved
(,15 or $15), pT stage (7
th AJCC classification), pN stage (7
th
AJCC classification), rN stage, LODDS stage, TNM stage (7
th
AJCC classification), TRM stage and TLM stage (Table 1).
During the study period we did not have a standardized
protocol for postoperative chemotherapy and (or) radiotherapy.
Adjuvant therapy was suggested to all patients with T3–T4
classification or positive lymph node involvement; however, only
548 (75.1%) patients completed the adjuvant treatments. No
patients received the adjuvant radiotherapy. Until July 2011, there
were 321 patients died from the disease.
Statistical analysis
All statistical analysis were performed by Statistical Package of
Social Sciences 13.0 software. P value,0.05 was considered to be
statistically significant. The Kaplan-Meier method was used to
estimate the 5-year overall survival. For patients who remained
alive, data were censored at the date of the last contact. Kaplan-
Meier analysis with log-rank testing was used for univariate
analysis. Overall survival rates were compared with different pN
and rN classification when stratifying by LODDS and with
different LODDS when stratifying by pN or rN classification. For
the multivariate analysis, we firstly set up a model including age,
status of anemia, size of tumor, tumor location, degree of
differentiation, total number of lymph nodes retrieved and AJCC
7th TNM staging system. Then we set up a second model which
was identical to the first one except that the AJCC 7th TNM
staging system was replaced by the TRM staging system. In the
third model we used the TLM staging system to replace the TRM
system. We used two parameters to compare the TNM, TRM and
TLM staging system, the 22log likelihood and the hazard ratio
(HR). The higher the HR, the better the system. While the smaller
the 22log likelihood, the better the system.
Table 5. Three steps multivariate analysis of overall survival in gastric carcinoma.
Factors Characteristics Multivariate Analysis 1 Multivariate Analysis 2 Multivariate Analysis 3
Unfavorable Favorable
Hazard
ratio 95%CI P value
Hazard
ratio 95%CI P value
Hazard
ratio 95%CI P value
Age $60 ,60 1.016 1.000–1.032 0.056 1.258 0.881–1.796 0.206 1.302 0.913–1.858 0.145
Anemia Yes No 1.509 0.975–2.335 0.065 1.692 1.099–2.606 0.017 1.710 1.110–2.635 0.015
Size $5c m ,5 cm 1.512 1.059–2.158 0.023 1.542 1.082–2.198 0.017 1.544 1.084–2.200 0.016





Well+Moderate 0.599 0.379–0.946 0.028 0.588 0.375–0.924 0.021 0.569 0.362–0.895 0.015
Totalnumberof
LNretrieved




III+IV I+II 1.366 1.166–1.601 ,0.001
TRM stage III+IV I+II 1.463 1.286–1.664 ,0.001
TLM stage III+IV I+II 1.504 1.320–1.713 ,0.001
Abbreviations: CI, confidence interval; LN, lymph node; AJCC, American Joint Committee on Cancer; TNM, Tumor-Node-Metastasis; TRM, Tumor-Ratio-Metastasis; TLM,
Tumor-Lodds-Metastasis.
doi:10.1371/journal.pone.0031736.t005
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